LifeVantage

LFVN

Market cap $84.6M

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

SALT LAKE CITY, Nov. 12, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced new in vitro study results for its proprietary P84 formula revealing strong biological activity in cellular pathways linked to gut regulation, repair, and restoration.* In the controlled, third-party study, targeted gene expression and protein concentration were measured using four gut cell types.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Lifevantage (LFVN) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.15 per share a year ago.

LifeVantage Corporation ( LFVN ) Q1 2026 Earnings Call November 4, 2025 4:30 PM EST Company Participants Steven Fife - President, CEO & Director Carl Aure - Chief Financial Officer Conference Call Participants Reed Anderson - ICR Inc. Douglas Lane - Water Tower Research LLC Presentation Operator Good afternoon, ladies and gentlemen. Thank you for standing by.

SALT LAKE CITY, Nov. 04, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company's Board of Directors has approved a quarterly cash dividend of $0.045 per share of common stock, which will be paid December 15, 2025 to all stockholders of record at the close of business on December 1, 2025.

SALT LAKE CITY, Nov. 04, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its first fiscal quarter ended September 30, 2025. First Quarter Fiscal 2026 Summary*: Revenue was $47.6 million, an increase of 0.7% from the prior year period.

SALT LAKE CITY, Oct. 28, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the successful conclusion of Momentum Academy 2025 , a dynamic, high-impact event that brought together thousands of Consultants from across the U.S. from October 23-25 at the Hilton Anatole in Dallas, TX. This year's event centered around the theme: “Love Life & Drive” – inspiring Consultants to take the driver's seat in their businesses with purpose, speed, and unstoppable momentum.

SALT LAKE CITY, Oct. 21, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its first quarter ended September 30, 2025, after the stock market closes on Tuesday, November 4, 2025. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.

SALT LAKE CITY, Oct. 13, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer will participate in the LD Micro Main Event XIX, to be held October 19-21, 2025 in San Diego, CA.